FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/01/079747 [Registered on: 29/01/2025] Trial Registered Prospectively
Last Modified On: 23/01/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Other 
Public Title of Study   MANAGEMENT OF INFECTED WOUND (NON-HEALING ULCER)IN PATIENTS OF AGE GROUP 18 TO 60 YEARS BY HIGH-FREQUENCY ELECTROTHERAPY AND AGNIKARMA 
Scientific Title of Study   MANAGEMENT OF DUSHTAVRANA (NON-HEALING ULCER)BY HIGH FREQUENCY ELECTROTHERAPY AND AGNIKARMA-A COMPARATIVE RANDOMIZED CLINICAL CONTROL STUDY IN 18 TO 60 YEARS OF AGE 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrPravin Bhaurao Chetule 
Designation  PG Scholar (Shalyatantra) 
Affiliation  Dayabhai Maoji Majithiya Ayurved Mahavidyalaya and L.K.Ayurved Rugnalaya,Yavatmal 
Address  Dayabhai Maoji Majithiya Ayurved Mahavidyalaya affiliated with L.K.Ayurved Rugnalaya,Department of Shalyatntra,Ground floor OPD No.05, Yavatmal

Yavatmal
MAHARASHTRA
445001
India 
Phone  9763622511  
Fax    
Email  pravinchetule@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrVihar R Bidwai 
Designation  Associate Professor, M.S.(Shalya), MBA, PhD(Sch.), FARCS & PG Guide  
Affiliation  Dayabhai Maoji Majithiya Ayurved Mahavidyalaya and L.K.Ayurved Rugnalaya,Yavatmal 
Address  Dayabhai Maoji Majithiya Ayurved Mahavidyalaya affiliated with L.K.Ayurved Rugnalaya,Department of Shalyatntra,Ground floor OPD No.05, Yavatmal

Yavatmal
MAHARASHTRA
445001
India 
Phone  9822299174  
Fax    
Email  drviharbidwai@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DrPravin Bhaurao Chetule 
Designation  PG Scholar (Shalyatantra) 
Affiliation  Dayabhai Maoji Majithiya Ayurved Mahavidyalaya and L.K.Ayurved Rugnalaya,Yavatmal 
Address  Dayabhai Maoji Majithiya Ayurved Mahavidyalaya affiliated with L.K.Ayurved Rugnalaya,Department of Shalyatntra,Ground floor OPD No.05, Yavatmal

Yavatmal
MAHARASHTRA
445001
India 
Phone  9763622511  
Fax    
Email  pravinchetule@gmail.com  
 
Source of Monetary or Material Support  
Dayabhai Maoji Majithiya Ayurved Mahavidyalaya affiliated with L.K.Ayurved Rugnalaya, Shivaji nagar, Aarni road, Yavatmal 445001 
 
Primary Sponsor  
Name  DMM Ayurved Mahavidyalaya,Yavatmal 
Address  Dayabhai Maoji Majithiya Ayurved Mahavidyalaya affiliated with L.K.Ayurved Rugnalaya, Department of Shalyatantra, Ground floor OPD No.05, Shivaji Nagar,Yavatmal, Aarni road Dist.Yavatmal 445001 
Type of Sponsor  Other [(Research institution and hospital)] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Pravin Bhaurao Chetule  Dayabhai Maoji Majithiya Ayurved Mahavidyalaya and L.K.Ayurved Rugnalaya,Yavatmal  OPD NO.05 Department of Shalyatantra, Shivaji nagar, Aarni road, Yavatmal 445001
Yavatmal
MAHARASHTRA 
9763622511

pravinchetule@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical committee, D.M.M. Ayurved Mahavidyalaya, Yavatmal  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: L089||Local infection of the skin and subcutaneous tissue, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  AGNIKARMA   Agnikarma has been explained as one among the Anushastra & Upayantra. Aacharya Sushrut had mentioned that a disease once treated by agnikarma does not re-occur and does not get infected easily. Therefore, Agnikarma has emerged as an integral part of Ayurvedic therapeutics. Through the mechanism of Agnikarma procedure reduce vaat,kapha from ulcer site and vacularization done in surrounding area as well as accelerate the blood circulation,Improve metabolism,reduce pain and inflamation from site. 
Intervention  HIGH-FREQUENCY ELECTROTHERAPY   The high frequency is used for skin, scalp and body treatment which has many benefits including treating acne, enlarged pores, fine lines, wounds and ulcers. The high frequency is through the high frequency electricity rate coagulation,urges the eqidermal cell necrosis,Which can be in instantaneous thoroughly eliminate all kinds blockages from blood vessels and improve wound healing process. It produces the ozone for sterilization,can help wound to heal. Accelerate blood circulation and improve metabolism. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. The patients of the age group 18-60 years.
2. The patients with symptoms of Dushtavrana irrespective of its dosha E.g.Shul,
Kandu, Strava, Gandh, Sparshasahtva.
3. Patients of any sex will be selected.
4. Marital Status – Both
5. Patient only of pre-diagnosed Dushtavrana.
6. Patient belonging to any socio-economic class.  
 
ExclusionCriteria 
Details  1. Age group below 18 years and above 60 years.
2. Pregnant and lactating mother.
3. Patients with other systemic diseases such as AIDS, TB, Diabetes Mellitus,
Malignancy, and Leprosy may affect the outcome of the treatment.
4. Ulcers with gangrenous changes.
5. Patient not willing to participate in study.
6. Osteomyelitis wounds.
7. Dagdha Vrana.  
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The parameters will be noted down before and after treatment.
1. Vedana (Severity of pain)
2. Kandu (Itching)
3. Gandh (Smell)
4. Strava (Discharge)
5. Sparshasahtva (Tenderness)  
0th, 7th,14st and 21th (28th
follow up) and then Follow
up will be taken on 45th days
to observe recurrence) 
 
Secondary Outcome  
Outcome  TimePoints 
1) No improvement - 0 % relief in signs and symptoms.
2) Poor improvement - 0%-25% relief in sign and symptoms.
3) Mild improvement – 26% to 50% relief in signs and symptoms.
4) Moderate improvement – 51% to 75 % relief in signs and symptoms.
5) Marked improvement – 76% to 100% relief in signs and symptoms.  
0th, 7th,14st and 21th (28th
follow up) and then Follow
up will be taken on 45th days
to observe recurrence) 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   10/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   A minor nonhealing ulcer may also affect a person’s daily chores, making him uncomfortable and restless. Nonhealing ulcer i.e., Vrana is considered to be the primary pathology in the field of surgery. Chronic Dustavranas which are found commonly now a days become a challenge to the medical community and trying to find out solutions. Growth of micro-organism i.e., secondary infections in the nonhealing ulcer has led to the indiscriminate and irritational use of antibiotics due to which resistant strains of micro-organism developed, making the use of antibiotics futile. Sushruta the father of surgery has scientifically classified in a systemic manner the properties of the wealth of clinical material and the principles of management of Vrana which is valuable and validated even today. The classification of nonhealing ulcers, their prognostic evaluation and management, insistence on primary suturing in clean wounds, avoidance of sepsis and excision of extruded omentum and careful suturing of intestinal perforation in the management of perforation are examples cited. Sushruta has emphasized total management of the Vrana from the earliest stage of vitiation of Dosha to total recovery in which he insisted on bringing back the site of the lesion to normally in cases of Vrana treatment.

Agnikarma has been explained as one among the Anushastra & Upayantra. He further mentioned that a disease once treated by Agnikarma does not re-occur and does not get infected easily. Therefore, Agnikarma has emerged as an integral part of Ayurvedic therapeutics.
 
Close